Neoplasm
Not recruitingA study to evaluate the safety and effectiveness of KD033 in patients with advanced or metastatic solid tumors
- Disease:Neoplasm
- Substances:–
France- Participants:18–64 years · 65+ years
- Sponsor:Kadmon Corporation LLC
Rare diseases
Investigational molecules
Locations
55 Corporate Drive, 08807-1265, United States
Kadmon Corporation LLC is engaged in clinical research focused on cancer, with activity centered on advanced solid tumors and metastatic disease. Its trial portfolio reflects interest in treatment approaches for patients with locally advanced and disseminated malignancies.
The sponsor’s clinical work in this area is directed toward evaluating therapeutic activity in difficult-to-treat tumor settings, with emphasis on early signals of efficacy alongside safety and tolerability.
Kadmon Corporation LLC runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.